Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure

被引:55
|
作者
Sanaka, T [1 ]
Funaki, T [1 ]
Tanaka, T [1 ]
Hoshi, S [1 ]
Niwayama, J [1 ]
Taitoh, T [1 ]
Nishimura, H [1 ]
Higuchi, C [1 ]
机构
[1] Tokyo Womens Med Univ, Daini Hosp Med Ctr, Dept Nephrol & Blood Purificat, Arakawa Ku, Tokyo 1168567, Japan
来源
NEPHRON | 2002年 / 91卷 / 01期
关键词
pentosidine; enzyme-linked immunosorbent assay; phosphatidylcholine hydroperoxide; chronic renal failure;
D O I
10.1159/000057606
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The plasma pentosidine levels in patients with renal disease were measured by a simple method which was established for plasma and urinary pentosidine determinations. The method, which can be completed within a few hours, involves pretreating plasma with proteolytic enzyme (pronase) and measuring the concentration of pentosidine in the sample by ELISA using antipentosidine antibodies. The prepared antibodies showed no cross-reaction with the raw materials for pentosidine synthesis or with compounds having similar structures. SIDS-PAGE indicated that the antibodies had a high purity. The reaction of the antibodies and keyhole limpet hemocyanin-pentosidine in the competitive ELISA system was inhibited by free pentosidine. Excellent standard curves for pentosidine determination were obtained. In actual measurements of clinical samples from patients, a good correlation (r=0.9356) was obtained between the values measured by ELISA and HPLC. The plasma pentosidine level in patients with renal disease correlated significantly with plasma creatinine, urea nitrogen, beta(2)-Microglobulin, and creatinine clearance, indicating its usefulness in evaluating the severity of renal disease. A significant elevation in plasma pentosidine levels was observed in mild renal dysfunction, whereas no significant increases in creatinine and urea nitrogen levels were detected, suggesting that the plasma pentosidine level is useful in the early diagnosis of beginning renal failure. In patients with chronic renal failure, no difference in plasma pentosidine levels was observed between diabetic nephropathy and chronic glomerulonephritis, while a significant correlation was observed with phosphatidylcholine hydroperoxide, suggesting the possibility that the plasma pentosidine level reflects injury due to oxidation. From these results, the quantitative measurement method developed by us is judged to be a superior innovation for measuring pentosidine in body fluids. The plasma pentosidine level may be useful for the early diagnosis of mild renal failure and to estimate the degree of the severity of renal diseases. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 50 条
  • [1] Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA
    Kobori, Hiroyuki
    Katsurada, Akemi
    Miyata, Kayoko
    Ohashi, Naro
    Satou, Ryousuke
    Saito, Toshie
    Hagiwara, Yoshiaki
    Miyashita, Kazuya
    Navar, L. Gabriel
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 294 (05) : F1257 - F1263
  • [2] ELEVATED LEVELS OF PLASMA LIPOFUSCINS IN PATIENTS WITH CHRONIC RENAL-FAILURE
    HEGEDUS, ZL
    FRANK, HA
    STEINMAN, TI
    ALTSCHULE, MD
    NAYAK, U
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1988, 96 (05): : 211 - 222
  • [3] PLASMA PENTOSIDINE LEVELS ARE ASSOCIATED WITH OSTEOCLASTIC ACTIVITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Nakano, Chikako
    Hamano, Takayuki
    Fujii, Naohiko
    Matsui, Isao
    Mikami, Satoshi
    Obi, Yoshitsugu
    Shimomura, Akihiro
    Rakugi, Hiromi
    Tsubakihara, Yoshiharu
    Isaka, Yoshitaka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 3 - 4
  • [4] Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease
    Saeki, Chisato
    Saito, Mitsuru
    Kanai, Tomoya
    Nakano, Masanori
    Oikawa, Tsunekazu
    Torisu, Yuichi
    Saruta, Masayuki
    Tsubota, Akihito
    PLOS ONE, 2021, 16 (04):
  • [5] Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody
    Ordonez, Adriana
    Yelamos, Jose
    Pedersen, Shona
    Minano, Antonia
    Conesa-Zamora, Pablo
    Kristensen, Soren R.
    Stender, Mogens T.
    Thorlacius-Ussing, Ole
    Martinez-Martinez, Irene
    Vicente, Vicente
    Corral, Javier
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) : 1143 - 1149
  • [6] Increased Urinary Levels of Pentosidine Measured by a Newly Developed Enzyme-Linked Immunosorbent Assay Are Independently Correlated with Fracture After Fall
    Tahara, Nobuhiro
    Tahara, Atsuko
    Maeda-Ogata, Shoko
    Yoshimura, Hanae
    Bekki, Munehisa
    Sugiyama, Yoichi
    Honda, Akihiro
    Igata, Sachiyo
    Nishino, Yuri
    Matsui, Takanori
    Fukami, Ako
    Enomoto, Mika
    Adachi, Hisashi
    Fukumoto, Yoshihiro
    Yamagishi, Sho-ichi
    REJUVENATION RESEARCH, 2021, 24 (06) : 449 - 455
  • [7] Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure
    Ishihara, T
    Yokota, N
    Hisanaga, S
    Fujimoto, S
    Hirayama, N
    Kato, J
    Kitamura, K
    Eto, T
    CLINICAL NEPHROLOGY, 1999, 52 (02) : 119 - 123
  • [8] PLASMA BETA-THROMBOGLOBULIN LEVELS IN CHRONIC-RENAL-FAILURE PATIENTS
    AKIZAWA, T
    NISHIYAMA, H
    KOSHIKAWA, S
    ARTIFICIAL ORGANS, 1981, 5 (01) : 54 - 58
  • [9] Association of plasma manganese levels with chronic renal failure
    Sanchez-Gonzalez, Cristina
    Lopez-Chaves, Carlos
    Gomez-Aracena, Jorge
    Galindo, Pilar
    Aranda, Pilar
    Llopis, Juan
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2015, 31 : 78 - 84
  • [10] PLASMA OXALATE LEVELS IN CHRONIC RENAL-FAILURE
    STONE, WJ
    FERGUSON, MC
    KIDNEY INTERNATIONAL, 1977, 12 (06) : 535 - 535